<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ep-patent-document PUBLIC "-//EPO//EP PATENT DOCUMENT 1.1//EN" "ep-patent-document-v1-1.dtd">
<ep-patent-document id="EP99924258B8W1" file="EP99924258W1B8.xml" lang="en" country="EP" doc-number="1077721" kind="B8" correction-code="W1" date-publ="20070620" status="c" dtd-version="ep-patent-document-v1-1">
<SDOBI lang="en"><B000><eptags><B001EP>ATBECHDEDKESFRGBGRITLILUNLSEMCPTIE......FI....CY................................</B001EP><B003EP>*</B003EP><B005EP>J</B005EP><B007EP>DIM360 (Ver 1.5  21 Nov 2005) -  2999001/0</B007EP></eptags></B000><B100><B110>1077721</B110><B120><B121>CORRECTED EUROPEAN PATENT SPECIFICATION</B121></B120><B130>B8</B130><B132EP>B1</B132EP><B140><date>20070620</date></B140><B150><B151>W1</B151><B153>73</B153><B155><B1551>de</B1551><B1552>Bibliographie</B1552><B1551>en</B1551><B1552>Bibliography</B1552><B1551>fr</B1551><B1552>Bibliographie</B1552></B155></B150><B190>EP</B190></B100><B200><B210>99924258.9</B210><B220><date>19990514</date></B220><B240><B241><date>20001211</date></B241><B242><date>20040114</date></B242></B240><B250>en</B250><B251EP>en</B251EP><B260>en</B260></B200><B300><B310>85714 P</B310><B320><date>19980515</date></B320><B330><ctry>US</ctry></B330></B300><B400><B405><date>20070620</date><bnum>200725</bnum></B405><B430><date>20010228</date><bnum>200109</bnum></B430><B450><date>20070502</date><bnum>200718</bnum></B450><B452EP><date>20061030</date></B452EP><B480><date>20070620</date><bnum>200725</bnum></B480></B400><B500><B510EP><classification-ipcr sequence="1"><text>A61K  39/385       20060101AFI19991203BHEP        </text></classification-ipcr><classification-ipcr sequence="2"><text>C07K   7/06        20060101ALI19991203BHEP        </text></classification-ipcr><classification-ipcr sequence="3"><text>C07K   7/08        20060101ALI19991203BHEP        </text></classification-ipcr></B510EP><B540><B541>de</B541><B542>VORBEUGUNG UND BEHANDLUNG VON HYPERGASTRINEMIE</B542><B541>en</B541><B542>PREVENTION AND TREATMENT OF HYPERGASTRINEMIA</B542><B541>fr</B541><B542>PREVENTION ET TRAITEMENT DE L'HYPERGASTRINEMIE</B542></B540><B560><B561><text>WO-A-97/28821</text></B561><B561><text>US-A- 5 023 077</text></B561><B561><text>US-A- 5 468 494</text></B561><B561><text>US-A- 5 607 676</text></B561><B561><text>US-A- 5 609 870</text></B561><B561><text>US-A- 5 622 702</text></B561><B562><text>WATSON SUSAN A ET AL: "Pre-clinical evaluation of the gastrimmune immunogen alone and in combination with 5-fluorouracil/leucovorin in a rat colorectal cancer model." INTERNATIONAL JOURNAL OF CANCER, vol. 75, no. 6, 16 March 1998 (1998-03-16), pages 873-877, XP002194963 ISSN: 0020-7136</text></B562><B562><text>SUMII MASAHARU ET AL: "Regulation of antral peptides by administration of omeprazole to healthy men." AMERICAN JOURNAL OF GASTROENTEROLOGY, vol. 89, no. 11, 1994, pages 2033-2037, XP001068668 ISSN: 0002-9270</text></B562><B562><text>MCCLOY R F ET AL: "Pathophysiological effects of long-term acid suppression in man." DIGESTIVE DISEASES AND SCIENCES, vol. 40, no. 2 SUPPL., 1995, pages 96S-120S, XP001068385 ISSN: 0163-2116</text></B562><B562><text>FRESTON JAMES W: "Long-term acid control and proton pump inhibitors: Interactions and safety issues in perspective." AMERICAN JOURNAL OF GASTROENTEROLOGY, vol. 92, no. 4 SUPPL., 1997, pages 51S-57S, XP001068667 ISSN: 0002-9270</text></B562><B562><text>REGULATORY PEPTIDES THORNDYKE M.: 'Identification and localization of material with gastrin-like immunoreactivity in the neutral ganglion of a photochordate, Ciona intestinalis' vol. 16, 1986, pages 269 - 279, XP002921542.</text></B562><B562><text>CANCER RESEARCH WATSON ET AL: 'Gastrimmune Raises Antibodies that Neutralize Amidated and Glycine extended Gastrin-17 and inhibit the growth of colon cancer' vol. 56, 1996, pages 880 - 885, XP002921543.</text></B562><B562><text>INT. J. CANCER WATSON ET AL: 'Anti-gastrin antibodies raised by gastrimmune inhibit growth of the human colorectal tumor AP5' vol. 61, 1995, pages 233 - 240, XP000654518.</text></B562><B565EP><date>20020515</date></B565EP></B560></B500><B600><B620EP><parent><cdoc><dnum><anum>07008760.6</anum></dnum><date>20070430</date></cdoc><cdoc><dnum><anum>07008761.4</anum></dnum><date>20070430</date></cdoc></parent></B620EP></B600><B700><B720><B721><snm>GEVAS, Philip, C.</snm><adr><str>881 Ocean Drive  23D</str><city>Key Biscayne, FL 33149</city><ctry>US</ctry></adr></B721><B721><snm>GRIMES, Stephen</snm><adr><str>551 Rutgers Drive</str><city>Davis, CA 95616</city><ctry>US</ctry></adr></B721><B721><snm>KARR, Stephen</snm><adr><str>2265 Halsey Circle</str><city>Davis, CA 95616</city><ctry>US</ctry></adr></B721><B721><snm>MICHAELI, Dov</snm><adr><str>21 Marina Vista Avenue</str><city>Larkspur, CA 94939</city><ctry>US</ctry></adr></B721><B721><snm>WATSON, Susan</snm><adr><str>5 Seatolla Close</str><city>Edwalton,
Nottingham NG2 6RB</city><ctry>GB</ctry></adr></B721></B720><B730><B731><snm>Receptor Biologix, Inc.</snm><iid>07889810</iid><irf>RTM/LEK</irf><adr><str>3350 W. Bayshore Road, Suite 150</str><city>Palo Alto, California 94303</city><ctry>US</ctry></adr></B731></B730><B740><B741><snm>Manaton, Ross Timothy</snm><sfx>et al</sfx><iid>00075061</iid><adr><str>Bromhead Johnson 
19 Buckingham Street</str><city>London WC2N 6EF</city><ctry>GB</ctry></adr></B741></B740></B700><B800><B840><ctry>AT</ctry><ctry>BE</ctry><ctry>CH</ctry><ctry>CY</ctry><ctry>DE</ctry><ctry>DK</ctry><ctry>ES</ctry><ctry>FI</ctry><ctry>FR</ctry><ctry>GB</ctry><ctry>GR</ctry><ctry>IE</ctry><ctry>IT</ctry><ctry>LI</ctry><ctry>LU</ctry><ctry>MC</ctry><ctry>NL</ctry><ctry>PT</ctry><ctry>SE</ctry></B840><B860><B861><dnum><anum>US1999010751</anum></dnum><date>19990514</date></B861><B862>en</B862></B860><B870><B871><dnum><pnum>WO1999059631</pnum></dnum><date>19991125</date><bnum>199947</bnum></B871></B870><B880><date>20010228</date><bnum>200109</bnum></B880></B800></SDOBI>
</ep-patent-document>
